# DNOW Inc.: financial statements, quarterly

DNOW · NYSE · CIK 1599617 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dnow.md) · [Financials](/companies/dnow/financials.md) · [Filings](/companies/dnow/filings.md) · [Insiders](/companies/dnow/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dnow/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [588](/filings/0000950170-24-123220.md) | [555 d](/filings/0001193125-26-072828.md) | [563](/filings/0000950170-25-065520.md) | [633](/filings/0000950170-25-103750.md) | [606](/filings/0001193125-25-266494.md) | [571 d](/filings/0001193125-26-072828.md) | [599](/filings/0001193125-26-211564.md) | [628](/filings/0001193125-26-338381.md) | [634](/filings/0001193125-25-266494.md) | [959 d](/filings/0001193125-26-072828.md) | [1,183](/filings/0001193125-26-211564.md) | [1,307](/filings/0001193125-26-338381.md) |
| Cost of revenue | $m | [454](/filings/0000950170-24-123220.md) | [421 d](/filings/0001193125-26-072828.md) | [434](/filings/0000950170-25-065520.md) | [495](/filings/0000950170-25-103750.md) | [471](/filings/0001193125-25-266494.md) | [442 d](/filings/0001193125-26-072828.md) | [461](/filings/0001193125-26-211564.md) | [499](/filings/0001193125-26-338381.md) | [489](/filings/0001193125-25-266494.md) | [909 d](/filings/0001193125-26-072828.md) | [990](/filings/0001193125-26-211564.md) | [1,064](/filings/0001193125-26-338381.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | [138](/filings/0001193125-26-211564.md) | [129](/filings/0001193125-26-338381.md) | not reported | not reported | [193](/filings/0001193125-26-211564.md) | [243](/filings/0001193125-26-338381.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | [109](/filings/0001193125-26-211564.md) | [112](/filings/0001193125-26-338381.md) | not reported | not reported | [243](/filings/0001193125-26-211564.md) | [238](/filings/0001193125-26-338381.md) |
| Operating income | $m | [37.0](/filings/0000950170-24-123220.md) | [36.0 d](/filings/0001193125-26-072828.md) | [28.0](/filings/0000950170-25-065520.md) | [33.0](/filings/0000950170-25-103750.md) | [23.0](/filings/0001193125-25-266494.md) | [25.0 d](/filings/0001193125-26-072828.md) | [29.0](/filings/0001193125-26-211564.md) | [17.0](/filings/0001193125-26-338381.md) | [33.0](/filings/0001193125-25-266494.md) | [(188) d](/filings/0001193125-26-072828.md) | [(50.0)](/filings/0001193125-26-211564.md) | [1.0](/filings/0001193125-26-338381.md) |
| Income tax | $m | [2.0](/filings/0000950170-24-123220.md) | [(115) d](/filings/0001193125-26-072828.md) | [8.0](/filings/0000950170-25-065520.md) | [8.0](/filings/0000950170-25-103750.md) | [9.0](/filings/0001193125-25-266494.md) | [6.0 d](/filings/0001193125-26-072828.md) | [7.0](/filings/0001193125-26-211564.md) | [3.0](/filings/0001193125-26-338381.md) | [7.0](/filings/0001193125-25-266494.md) | [(33.0) d](/filings/0001193125-26-072828.md) | [(16.0)](/filings/0001193125-26-211564.md) | [12.0](/filings/0001193125-26-338381.md) |
| Net income | $m | [35.0](/filings/0000950170-24-123220.md) | [150 d](/filings/0001193125-26-072828.md) | [21.0](/filings/0000950170-25-065520.md) | [24.0](/filings/0000950170-25-103750.md) | [13.0](/filings/0001193125-25-266494.md) | [20.0 d](/filings/0001193125-26-072828.md) | [21.0](/filings/0001193125-26-211564.md) | [14.0](/filings/0001193125-26-338381.md) | [25.0](/filings/0001193125-25-266494.md) | [(161) d](/filings/0001193125-26-072828.md) | [(44.0)](/filings/0001193125-26-211564.md) | [(21.0)](/filings/0001193125-26-338381.md) |
| Diluted EPS | $ per share | [0.32](/filings/0000950170-24-123220.md) | not reported | [0.19](/filings/0000950170-25-065520.md) | [0.21](/filings/0000950170-25-103750.md) | [0.12](/filings/0001193125-25-266494.md) | not reported | [0.19](/filings/0001193125-26-211564.md) | [0.13](/filings/0001193125-26-338381.md) | [0.23](/filings/0001193125-25-266494.md) | not reported | [(0.24)](/filings/0001193125-26-211564.md) | [(0.11)](/filings/0001193125-26-338381.md) |
| Basic EPS | $ per share | [0.32](/filings/0000950170-24-123220.md) | not reported | [0.20](/filings/0000950170-25-065520.md) | [0.21](/filings/0000950170-25-103750.md) | [0.12](/filings/0001193125-25-266494.md) | not reported | [0.19](/filings/0001193125-26-211564.md) | [0.13](/filings/0001193125-26-338381.md) | [0.23](/filings/0001193125-25-266494.md) | not reported | [(0.24)](/filings/0001193125-26-211564.md) | [(0.11)](/filings/0001193125-26-338381.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [194](/filings/0000950170-23-058182.md) | [299](/filings/0000950170-25-021784.md) | [188](/filings/0000950170-24-057616.md) | [197](/filings/0000950170-24-092492.md) | [261](/filings/0000950170-24-123220.md) | [256](/filings/0001193125-26-072828.md) | [219](/filings/0000950170-25-065520.md) | [232](/filings/0000950170-25-103750.md) | [266](/filings/0001193125-25-266494.md) | [164](/filings/0001193125-26-338381.md) | [116](/filings/0001193125-26-211564.md) | [114](/filings/0001193125-26-338381.md) |
| Current assets | $m | [1,033](/filings/0000950170-23-058182.md) | [1,068](/filings/0000950170-25-021784.md) | [1,045](/filings/0000950170-24-057616.md) | [1,023](/filings/0000950170-24-092492.md) | [1,058](/filings/0000950170-24-123220.md) | [1,028](/filings/0001193125-26-072828.md) | [1,067](/filings/0000950170-25-065520.md) | [1,080](/filings/0000950170-25-103750.md) | [1,096](/filings/0001193125-25-266494.md) | [2,278](/filings/0001193125-26-338381.md) | [2,250](/filings/0001193125-26-211564.md) | [2,117](/filings/0001193125-26-338381.md) |
| Total assets | $m | [1,376](/filings/0000950170-23-058182.md) | [1,532](/filings/0001193125-26-072828.md) | [1,594](/filings/0000950170-24-057616.md) | [1,563](/filings/0000950170-24-092492.md) | [1,587](/filings/0000950170-24-123220.md) | [1,621](/filings/0001193125-26-072828.md) | [1,651](/filings/0000950170-25-065520.md) | [1,661](/filings/0000950170-25-103750.md) | [1,660](/filings/0001193125-25-266494.md) | [3,924](/filings/0001193125-26-338381.md) | [3,927](/filings/0001193125-26-211564.md) | [3,816](/filings/0001193125-26-338381.md) |
| Current liabilities | $m | [423](/filings/0000950170-23-058182.md) | [418](/filings/0000950170-25-021784.md) | [462](/filings/0000950170-24-057616.md) | [412](/filings/0000950170-24-092492.md) | [417](/filings/0000950170-24-123220.md) | [442](/filings/0001193125-26-072828.md) | [460](/filings/0000950170-25-065520.md) | [455](/filings/0000950170-25-103750.md) | [435](/filings/0001193125-25-266494.md) | [974](/filings/0001193125-26-338381.md) | [929](/filings/0001193125-26-211564.md) | [991](/filings/0001193125-26-338381.md) |
| Total liabilities | $m | [469](/filings/0000950170-23-058182.md) | [466](/filings/0000950170-25-021784.md) | [515](/filings/0000950170-24-057616.md) | [464](/filings/0000950170-24-092492.md) | [469](/filings/0000950170-24-123220.md) | [493](/filings/0001193125-26-072828.md) | [507](/filings/0000950170-25-065520.md) | [500](/filings/0000950170-25-103750.md) | [475](/filings/0001193125-25-266494.md) | [1,686](/filings/0001193125-26-338381.md) | [1,784](/filings/0001193125-26-211564.md) | [1,718](/filings/0001193125-26-338381.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-072828.md) | not reported | not reported | not reported | [411](/filings/0001193125-26-338381.md) | [571](/filings/0001193125-26-211564.md) | [474](/filings/0001193125-26-338381.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [904](/filings/0000950170-23-058182.md) | [1,060](/filings/0000950170-25-021784.md) | [1,076](/filings/0000950170-24-057616.md) | [1,095](/filings/0000950170-24-092492.md) | [1,114](/filings/0000950170-24-123220.md) | [1,124](/filings/0001193125-26-072828.md) | [1,139](/filings/0000950170-25-065520.md) | [1,156](/filings/0000950170-25-103750.md) | [1,182](/filings/0001193125-25-266494.md) | [2,233](/filings/0001193125-26-338381.md) | [2,138](/filings/0001193125-26-211564.md) | [2,093](/filings/0001193125-26-338381.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.0 d](/filings/0000950170-24-123220.md) | [105 d](/filings/0001193125-26-072828.md) | [81.0](/filings/0000950170-25-065520.md) | [21.0 d](/filings/0000950170-25-103750.md) | [74.0 d](/filings/0001193125-25-266494.md) | [122 d](/filings/0001193125-26-072828.md) | [(16.0)](/filings/0001193125-26-211564.md) | [45.0 d](/filings/0001193125-26-338381.md) | [43.0 d](/filings/0001193125-25-266494.md) | [83.0 d](/filings/0001193125-26-072828.md) | [(95.0)](/filings/0001193125-26-211564.md) | [133 d](/filings/0001193125-26-338381.md) |
| Capital expenditure | $m | [4.0 d](/filings/0000950170-24-123220.md) | [2.0 d](/filings/0001193125-26-072828.md) | [1.0](/filings/0000950170-25-065520.md) | [3.0 d](/filings/0000950170-25-103750.md) | [2.0 d](/filings/0001193125-25-266494.md) | [3.0 d](/filings/0001193125-26-072828.md) | [6.0](/filings/0001193125-26-211564.md) | [4.0 d](/filings/0001193125-26-338381.md) | [4.0 d](/filings/0001193125-25-266494.md) | [7.0 d](/filings/0001193125-26-072828.md) | [8.0](/filings/0001193125-26-211564.md) | [9.0 d](/filings/0001193125-26-338381.md) |
| Share repurchases | $m | [5.0 d](/filings/0000950170-24-123220.md) | [1.0 d](/filings/0001193125-26-072828.md) | [1.0](/filings/0000950170-25-065520.md) | [10.0 d](/filings/0000950170-25-103750.md) | [7.0 d](/filings/0001193125-25-266494.md) | [5.0 d](/filings/0001193125-26-072828.md) | [8.0](/filings/0001193125-26-211564.md) | [19.0 d](/filings/0001193125-26-338381.md) | [0.0 d](/filings/0001193125-25-266494.md) | [10.0 d](/filings/0001193125-26-072828.md) | [50.0](/filings/0001193125-26-211564.md) | [25.0 d](/filings/0001193125-26-338381.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [111](/filings/0000950170-23-058182.md) | [111](/filings/0000950170-24-057616.md) | [108](/filings/0000950170-24-092492.md) | [108](/filings/0000950170-24-123220.md) | [107](/filings/0000950170-25-065520.md) | [108](/filings/0000950170-25-103750.md) | [107](/filings/0001193125-25-266494.md) | [107](/filings/0001193125-26-211564.md) | [106](/filings/0001193125-26-338381.md) | [106](/filings/0001193125-25-266494.md) | [186](/filings/0001193125-26-211564.md) | [182](/filings/0001193125-26-338381.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 180,785,891 at 2026-07-29, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-338381.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.